USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke DISCERNA wurde als Wortmarke am 05.07.2001 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 20.09.2005 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".
| Markenform | Wortmarke |
| Aktenzeichen | 78072439 |
| Registernummer | 2996887 |
| Anmeldedatum | 05. Juli 2001 |
| Veröffentlichungsdatum | 28. Juni 2005 |
| Eintragungsdatum | 20. September 2005 |
Markeninhaber
BABRAHAM HALL, BABRAHAM
CB2 4AT CAMBRIDGE
GB
CB2 4AT CAMBRIDGE
GB
Markenvertreter
Waren und Dienstleistungen
5
Antibody based therapy and prophylaxis products, and pharmaceutical and biochemical substances and preparations, namely, vaccines, reagents for medical diagnostic purposes and medical research applications, antibodies, immunoglobins, immunoconjugates, protein conjugates, antibody conjugates, cell-lines secreting antibodies and fusion proteins, radioactive and detectably labelled preparations and substances for medical and veterinary use; diagnostic and analytical products, namely, peptides, enzymes and functional portions of proteins being protein domains for medical and veterinary purposes; pharmaceutical and biochemical preparations for the treatment of cancer, osteoarthritis, rheumatoid arthritis, and degenerative muscular disorders
10
Instruments and apparatus for the administration of antibody-based therapy and prophylaxis preparations and substances, namely, medical syringes and injectors for medical purposes and gas-powered or spring powered needle free injectors
42
Biotechnology services, namely, development of new technology for others in the field of biotechnology; scientific and medical research and development, including contract research services; medical services; licensing of intellectual property; high throughput screening services for the detection and measurement of interactions between drugs, drug targets, proteins, protein domains, peptides, enzymes, ligands, and receptors; product development consultation, namely, advisory services relating to diagnostic products
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1378072439